Clinical Trials List
2008-05-01 - 2010-12-31
Phase III
Terminated4
ICD-10B44.1
Other pulmonary aspergillosis
ICD-10B44.2
Tonsillar aspergillosis
ICD-10B44.7
Disseminated aspergillosis
ICD-10B44.89
Other forms of aspergillosis
ICD-10B44.9
Aspergillosis, unspecified
ICD-10B48.4
Penicillosis
ICD-9117.3
Aspergillosis
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Hui-Hua Hsiao Division of Hematology & Oncology
- Yen-Hsu Chen Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 余垣斌 Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- 陳苓萍 Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- FANG-LIANG HUANG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林皇伸 Division of Hematology & Oncology
- Po-Nan Wang Division of Hematology & Oncology
- 葉忠智 Division of Hematology & Oncology
- Ming-Chung Kao Division of Hematology & Oncology
- 洪玉馨 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
335 participants
